06.01.05
Research recently presented at the American College of Cardiology’s annual meeting has suggested that D-Ribose might improve ventilatory efficiency among patients with congestive heart failure (CHF). D-Ribose, a naturally occurring monosaccharide, has been shown to play a vital role in cellular energy creation. A team at the University of Utah tested the effects of D-Ribose on the exercise capacity and ventilatory efficiency of CHF patients. Using a randomized, double-blind, placebo-controlled, crossover design the effect of ribose supplementation was tested on 15 CHF patients for 8 weeks. According to researchers, this study showed a real benefit in ventilatory parameters during cardiopulmonary exercise testing, with a significant improvement noted in ventilatory efficiency, oxygen uptake efficiency and myocardial performance in class II and III heart failure patients.